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Amyloid Formation at Atomic Resolution
Timo Eichner,1 Arnout P. Kalverda,1 Gary S. Thompson,1 Steve W. Homans,1 and Sheena E. Radford1,*




Numerous studies of amyloid assembly have indi-
cated that partially folded protein species are
responsible for initiating aggregation. Despite their
importance, the structural and dynamic features of
amyloidogenic intermediates and the molecular
details of how they cause aggregation remain
elusive. Here, we use DN6, a truncation variant of
the naturally amyloidogenic protein b2-microglobulin
(b2m), to determine the solution structure of a nonna-
tive amyloidogenic intermediate at high resolution.
The structure of DN6 reveals a major repacking of
the hydrophobic core to accommodate the nonna-
tive peptidyl-prolyl trans-isomer at Pro32. These
structural changes, together with a concomitant
pH-dependent enhancement in backbone dynamics
on a microsecond-millisecond timescale, give rise
to a rare conformer with increased amyloidogenic
potential. We further reveal that catalytic amounts
of DN6 are competent to convert nonamyloidogenic
human wild-type b2m (Hb2m) into a rare amyloido-
genic conformation and provide structural evidence
for the mechanism by which this conformational
conversion occurs.
INTRODUCTION
A number of human diseases involve protein misfolding events
that ultimately result in the malfunctioning of the cellular
machinery (Welch, 2004; Gidalevitz et al., 2006). In one class of
these disorders, normally soluble proteins self-associate to
form fibrillar aggregates known as amyloid (Westermark et al.,
2007). Studies have suggested that equilibration between
a natively folded protein and one or more partially or more highly
unfolded species is a key initiating event in amyloid formation
(Booth et al., 1997; Calamai et al., 2005). In particular, for trans-
missible spongiform encephalopathies, the protein-only hypoth-
esis describes the potential of infectious nonnative protein
conformations (PrPSC) to transmit their biophysical properties
onto native protein conformers (PrPC), leading to the propaga-
tion of protein misfolding and aggregation (Sindi and Serio,
2009). Studies on Alzheimer’s disease, Parkinson’s disease,
and systemic and senile amyloidosis (Kane et al., 2000; Lund-
mark et al., 2002; Rocken and Shakespeare, 2002; Xing et al.,
2002; Angot and Brundin, 2009) have suggested that prion-like
behavior may be a general feature of misfolded proteins (Brundin
et al., 2010). However, the molecular mechanism of conforma-
tional conversion remains elusive.
Crucial to the understanding of the early stages of amyloid
assembly is the elucidation of the structural changes that occur
when a normally soluble protein becomes aggregation prone.
Structural investigation of early aggregation-prone species is
hampered, however, by their transient nature, heterogeneity,
and instability (Calamai et al., 2005; Jahn and Radford, 2008).
In general, the creation of unsatisfied hydrogen bond donors
and acceptors, increased hydrophobic surface area, and/or
loss of so-called negative design features (Richardson and
Richardson, 2002) has been implicated in increasing amyloid
potential (Liu et al., 2000; Monti et al., 2005; Ahn et al., 2006;
Qin et al., 2007; Calabrese et al., 2008). However, the structural
details of such changes and precisely how they engender
amyloidogenicity remain unclear.
Here, we utilized b2-microglobulin (b2m), a 99-residue protein
with an immunoglobulin fold (Becker and Reeke, 1985), to inves-
tigate the initiating events of amyloid assembly in all-atom detail.
b2m is the major component of fibrillar deposits in patients with
dialysis-related amyloidosis (DRA) (Gejyo et al., 1985). While
the concentration of monomeric b2m is a risk factor for amyloid
deposition in DRA, the native monomer is not able to assemble
into amyloid fibrils spontaneously at neutral pH in the absence
of additional factors (reviewed in Calabrese and Miranker,
2009; Platt and Radford, 2009). Instead, an increase in concen-
tration of the nonnative, amyloidogenic precursor IT, a mono-
meric b2m conformer that contains a nonnative peptidyl-prolyl
trans-isomer of Pro32, has been shown to be a key trigger of
amyloid formation (Chiti et al., 2001; Jahn et al., 2006; Eichner
and Radford, 2009). Furthermore, the presence of a trans-prolyl
peptide bond at residue 32 (rather than trans-Ala32, Val32, or
Gly32 [Eakin et al., 2006; Jahn et al., 2006; Sakata et al., 2008])
is required to form a species able to nucleate amyloid formation,
presumably because of conformational restrictions imposed by
the X-Pro32 trans-peptide bond itself (Eichner and Radford,
2009). The detailed structural changes occurring during inter-
conversion between native b2m and the IT state, however,
remain elusive, despite a number of studies using NMR (Jahn
et al., 2006; Mimmi et al., 2006; Kameda et al., 2009; Corazza
et al., 2010) and X-ray crystallography (Eakin et al., 2006; Calabr-
ese et al., 2008).
Here, we usedDN6, a truncation variant of human b2m found in
amyloid deposits of patients with DRA that lacks the N-terminal
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six amino acids and closely mimics IT (Eichner and Radford,
2009), to determine the solution structure of this nonnative, amy-
loidogenic intermediate at high resolution using NMR spectros-
copy. The results reveal a remarkable repacking of the hydro-
phobic core that is reminiscent of, but distinct from, the
nonamyloidogenic Cu2+-bound hexameric state previously
captured by crystallography (Calabrese et al., 2008). Most strik-
ingly, we show that DN6 is able to interact specifically with
human wild-type b2m (Hb2m), causing it to adopt an amyloid-
competent structure and thereby reveal the mechanism of
conformational conversion of a naturally occurring amyloido-
genic protein in atomistic detail.
RESULTS
Real-Time NMR Studies Confirm the Structural
Resemblance of DN6 and IT
To confirm the structural similarity of DN6 with the slow-folding
intermediate, IT, that is known to be highly amyloidogenic (Chiti
et al., 2001; Jahn et al., 2006; Eichner and Radford, 2009),
Hb2m was denatured in 8 M urea and then refolded by 10-fold
dilution into buffer at pH 7.5, 25C. SOFAST 1H-15N heteronu-
clear multiple-quantum coherence (HMQC) spectra (Schanda
and Brutscher, 2005) were then acquired approximately 2 min
after refolding commenced, at which time IT is populated to
about 75% (Eichner and Radford, 2009) (Figure 1A). The spec-
trum reveals 76 cross-peaks corresponding to the IT state,
68 of which overlay with resonances of DN6 (1H/15N within ±
0.04/0.2 ppm, respectively). Figure 1B shows one region of the
SOFAST 1H-15N HMQC spectra obtained at different folding
times. The data show that resonances arising from the kinetically
formed IT superpose with those of DN6 at equilibrium. The peaks
corresponding to IT then decrease in intensity with increased
folding time, as resonances of the native state emerge. Reso-
nances in the spectrum of DN6 were assigned using standard
procedures (see below). Figure 1C shows the difference in
chemical shift of the 76 cross-peaks identified for IT by compar-
ison with the assigned spectrum of DN6. The data reveal
Figure 1. 1H-15N SOFAST HMQC Spectra and Chemical Shift Analysis of DN6 and IT
(A) Spectra of DN6 (250 mM, red) and IT (250 mM green), the latter obtained approximately 2 min after refolding Hb2m from 8 M urea (pH 7.5, 25
C).
(B) Panels showing the amide resonances of Glu69, Val93, and Asp96 in DN6 (red), native Hb2m (black), and IT (green), the latter obtained approximately 2 min, 5
min, 10 min, and 20 min after refolding commenced.
(C) Comparison of the chemical shifts of DN6 and IT for the 76
1H or 15N resonances that were identified in the spectrum of both species. Note that the chemical
shift differences ofDN6 and IT aremore than one order ofmagnitude smaller than the chemical shift differences of Hb2mandDN6 (compare Figure 1Cwith Figures
2B and 2D). Missing 1H-15N resonances in the spectrum of IT (1–7, 29, 30, 33, 53, 55–61, 86, and 88) are either broadened due to intermediate exchange
processes or degenerate with other residues. The rainbow ribbons and numbers above indicate b strands in Hb2m calculated from the final set of 30 lowest-
energy structures (PDB code 2XKS) using DSSPcont (Carter et al., 2003). All samples contained 0.8 M urea.
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differences in chemical shift of <0.2 ppm (1H) or 0.8 ppm (15N),
confirming the fidelity of DN6 as a structural mimic of IT.
The Structure of DN6
To allow detailed comparison of the structure and dynamics of
DN6 and native Hb2m, chemical shift assignment of the spectra
of both proteins was carried out (Figure S1). 1H-15N assignments
were obtained for 88 out of 99 residues of Hb2m and 84 out of 93
residues of DN6. 1H-13C side-chain assignments were obtained
for 95% of residues in Hb2m and 90% of residues for DN6. The
results indicate, as anticipated, that the X-Pro32 peptide bond
adopts a trans-conformation in DN6 (Table S1). Moreover,
comparison of the chemical shift differences between Hb2m
and DN6 (Figures 2A–2F) revealed that of the 93 residues in
DN6, approximately 60 residues (i.e., more than half of the mole-
cule) (Figure 2G) have chemical shifts that deviate substantially
(D1H/15N/13C > 0.2/0.8/0.4 ppm for all resonances analyzed)
from the values for native Hb2m. While many of these residues
lie in spatial proximity to Pro32 in native Hb2m (Trinh et al.,
2002), some are distant to this site, consistent with Pro32 being
Figure 2. Chemical Shift Analysis of Native Hb2m and DN6
(A–F) Differences in chemical shift of Ca (A), HN (B), Ha (C), NH (D), C0 (E), and Cb (F) between native Hb2m and DN6 (pH 7.5, 25
C). Rainbow-colored ribbons and
numbers above indicate the secondary structure contents of Hb2m and DN6.
(G) Lowest-energy structure of Hb2m (PDB code 2XKS) showing the eight native b strands: A (6–11), B (21–28), C (36–41), C
0 (44–45), D (50–51), E (64–70),
F (79–83), and G (91–94). Residues colored in red differ significantly (D1H/15N/13C > 0.2/0.8/0.4 ppm) in chemical shift between Hb2m and DN6. Pro32 (stick,
spheres) is highlighted (see also Figure S1 and Table S1).
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the epicenter of widespread conformational changes in DN6
(Figure 2G).
To determine the structures of native Hb2m and DN6, 2065 or
2565 nuclear Overhauser enhancements (nOe) (Tables 1 and
S2), 128 or 118 dihedral angles, and 75 or 76 residual dipolar
couplings (RDC) were obtained for each protein, respectively
(Table 1). Structural ensembles were then calculated using the
PASD algorithm (Kuszewski et al., 2004) to obtain 50 preliminary
structures that were transferred into ARIA 2.0 (Rieping et al.,
2007) for further refinement (see Supplemental Experimental
Procedures). In the final ensemble of 30 structures (Figure 3A),
the rmsd of backbone atoms (1H, 15N, 13Ca, 13C0) within ordered
regions is 0.42 and 0.28 A˚ from the mean structures of native
Hb2m and DN6, respectively. The structural ensembles reveal
that DN6 retains a native-like b sandwich fold containing two
antiparallel b sheets tethered by a single disulfide bridge
between Cys25 and Cys80 (Figure 3A). Minor differences are
observed in the lengths of b strands, including the short D strand
that adopts variable structures in DN6 (see Supplemental Exper-
imental Procedures). Despite being highly amyloidogenic,
Table 1. NMR and Refinement Statistics of Native Hb2m and DN6
(pH 7.5, 25C)
NMR Distance
and Dihedral Constraints Native Hb2m DN6
Distance Constraints
Total nOe 2065 2565
Intraresidue 782 732
Interresidue 1283 1833




Long-range (ji-jjR 5) 698 1021
Intermolecular 0 0







Structure Statistics Native Hb2m DN6
Violations (Mean and SD)
Distance constraints (A˚) 0.155 ± 0.007 0.056 ± 0.005
Dihedral angle
constraints ()







RDC Q 0.33 ± 0.22 0.43 ± 0.24
Average RDC
violation ()
0.64 ± 0.06 0.78 ± 0.06
Deviations from
Idealized Geometry
Bond length (A˚) 0.0056 ± 0.0002 0.0060 ± 0.0001
Bond angle () 0.72 ± 0.02 0.82 ± 0.02
Impropers () 1.87 ± 0.11 2.05 ± 0.15
Average Pairwise Rmsd* (A˚)
Heavy 1.218 0.984
Backbone 0.415 0.277
* Pairwise rmsds were calculated over ordered regions from an ensemble
of 30 structures superimposing the restrained residues in native Hb2m
(3–28, 30–31, 34–45, 48–53, 55–57, 63–86, 89–98) andDN6 (7–28, 31–52,
64–86, 89–98).
Figure 3. Solution Structures of Native Hb2m and DN6
(A) Cartoon representation of five lowest-energy structures of native Hb2mand
DN6 with b strands highlighted in rainbow colors. The cartoon overlay shows
the lowest-energy structures of native Hb2m (black) and DN6 (red). Pro32
(sticks, spheres) and the disulfide bond (Cys25-Cys80, sticks) are highlighted.
(B) Bar chart showing the Ca rms (A˚) of the overlay shown in (A). The rainbow-
colored arrows above indicate residues involved in b strand structure of Hb2m
and DN6.
(C) Overlay of lowest-energy structures of native Hb2m (black) and DN6 (red).
Residues Pro32, Phe30, Phe62, His84, Leu64, Ile35, Phe70, and Trp95 and the
disulfide bond (Cys25-Cys80, sticks) are highlighted. Structures were drawn
using PyMOL (DeLano, 2002) (see also Figure S2 and Table S2).
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therefore, DN6 contains a well-defined structure under the
conditions employed that, in terms of the main chain, is not
significantly perturbed compared with native Hb2m (within
ordered regions, the Ca rms between Hb2m and DN6 is approx-
imately 1.3 A˚) (Figure 3B).
In contrast with the minor differences in the main chain of
Hb2m and DN6, dramatic differences are observed for side
chains, both close to Pro32 and distal to this site, that result
from a substantial repacking of the molecule’s core (Figure 3C).
Of the 21 residues that comprise the hydrophobic core of native
Hb2m, 17 undergo significant movement (>2 A˚) between the two
structures (Tables 1 and S2). Most strikingly, the aromatic side
chain of Phe30 moves out of the hydrophobic core in DN6
toward the surface where the N terminus was originally placed
(Figure 3C). This large movement (Hz of Phe30 moves by
9.5 A˚) is accompanied by further restructuring of side chains
in the core (Figure 3C). In particular, the X-Pro32 cis-peptide
bond is relaxed toward the more favored trans-peptidyl-prolyl
isomer (Hgmoves by 9.6 A˚). As a consequence, the backbone
(1H, 15N, 13C0) interactions between Phe30 and Phe62 are disrup-
ted so that the side chain of the latter rotates by >90 around Cg
and loses connection with the BC-loop (Cg moves by 7.4 A˚)
(Figure 3C). The change in rotameric state of Phe30 also disrupts
the main-chain hydrogen bonding between Ser28 and Lys6/
Met6 in the A andB strands, leading to a loss in b strand structure
at these residues and causing the side chain of His84 to rotate
around its Cg by 45 (Figure 3C). The cavity left by Phe30 is
mostly filled by the hydrophobic side chains of Pro32, Leu64,
and Ile35, the latter two side chains changing their rotamer
angles so as to accomplish this. The conformational changes
that result from isomerization of the X-Pro32 peptide bond do
not stop at Cys25-Cys80 disulfide, but propagate deep into
the other half of the molecule, leading to movements of the
side chains of Asn21, Phe70, Phe78, and Trp95 (Figure 3C).
These side-chain movements result in differences in surface
charge and hydrophobicity (Figure S2A), consistent with
previous suggestions that the N terminus of Hb2m is important
in maintaining the native hydrophobic folding balance (Esposito
et al., 2000). The data thus show that docking of the N-terminal
hexapeptide during the last steps in folding locks Hb2m into
a thermodynamically stable native structure that contains an
unfavorable X-Pro32 cis-peptide bond. Consistent with this,
resonances arising from the N-terminal seven residues were
not identified in the HMQC spectrum of IT (Figure 1A), suggesting
that this region is displaced from its native conformation in the
folding intermediate. Once the N-terminal hexapeptide is dis-
placed, or removed as in DN6, the molecule relaxes toward an
amyloidogenic conformation containing the X-Pro32 trans-
isomer.
The Dynamics of DN6 Reveal a Rarely Populated
Nucleation- and Elongation-Competent Species
DN6 has been shown to be highly aggregation prone compared
with Hb2m, suggesting that this variant is uniquely able to
sample one or more amyloidogenic conformers at physiological
pH (Esposito et al., 2000; Eichner and Radford, 2009). Accord-
ingly, amyloid fibrils are obtained after incubation of DN6 at
37C, pH 7.2 in a protein-concentration-dependent manner
(Figure 4A). While DN6 converts quantitatively into insoluble
aggregates, as indicated by a lack of residual monomer in the
supernatant after fibrillation is complete, as judged by SDS-
PAGE (see Experimental Procedures) (data not shown), native
Hb2m does not show an increase in ThT fluorescence and
remains soluble (judged by SDS-PAGE, data not shown) even
after 50 days incubation (Figure 4A). Further experiments
revealed that the amyloidogenicity of DN6 is highly pH depen-
dent: no fibrils result when the protein (80 mM) is incubated at
pH 8.2 for 50 days, while the protein converts into amyloid fibrils
at pH 6.2 more rapidly (tlag = 15 ± 4 days) than at pH 7.2 (tlag =
35 ± 4 days) at this protein concentration (compare Figures 4A
and 4B). Replacing His84 (a residue in close proximity to Pro32)
(Figure 3C) with alanine in DN6 substantially reduces the ability
of this protein to assemble de novo into amyloid fibrils (Fig-
ure 4C). The rate of elongation of fibrillar seeds of DN6 by
DN6 monomers is also enhanced at pH 6.2 compared with
pH 8.2 (Figure 4D). The data indicate, therefore, that proton-
ation of His84 and possibly other side chains with pKa 7
amplifies the amyloidogenicity of DN6, presumably by causing
conformational changes that increase the population of species
with enhanced amyloid potential within the ensemble of struc-
tures available.
To explore in more detail the enhanced ability of DN6 to
nucleate amyloid formation compared with Hb2m, the dynamic
properties of the two proteins were compared. Whereas
15N R1 and {
1H}15N nOe relaxation measurements show limited
motions on a picosecond-to-nanosecond timescale for both
proteins (Figure S2B), significantly higher 15N R2 relaxation rates
were observed for residues 25–34 (BC-loop) in DN6 compared
with Hb2m (Figures 4E and 4F). Additionally, several residues
in the DE-loop (54–57, 59, 61–63) of DN6 relax too rapidly
(R2R 25 s
1, indicated by gray bars in Figures 4F–4H) to deter-
mine their R2 rates reliably but were readily quantified for Hb2m,
suggestive of enhanced chemical exchange processes on
a microsecond-to-millisecond timescale for these residues in
the former protein (Figures 4E and 4F). The local dynamics of
residues 25–34 (BC-loop) and 51–66 (DE-loop) of DN6 are
dependent on pH, with complete suppression of their enhanced
dynamics at pH 8.2 and significant enhancement relative to
other residues at pH 6.2 (Figure 4G), consistent with the pH
dependency of fibril formation. Finally, the pH-dependent
increase in R2 dynamics of residues 25–34 in DN6/H84A is
substantially reduced at pH 6.2 compared with DN6 (Figures
4G and 4H), consistent with the view that protonation of His84
plays a role in enhancing the dynamics of the BC-loop (Figure 4I)
and the amyloidogenicity of DN6. Analysis of 1H-15N HSQC
spectra of DN6 at increased protein concentration revealed
a set of resonances (in the BC- and DE-loops) that shifted signif-
icantly dependent on the protein concentration, suggesting that
fibril formation of DN6 occurs by transient oligomerization via
a newly formed dimerization interface involving these residues
(Figures S3A and S3B). Importantly, a clear correlation is
observed between chemical shift alterations of DN6 with pH
and protein concentration (data not shown). These data suggest
that protonation events and protein conformational changes are
coupled processes that together initiate the aggregation
cascade.
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Figure 4. Amyloid Formation and Protein Dynamics of Native Hb2m and DN6
(A) De novo fibril formation of 500 mM DN6 (red), 80 mM DN6 (blue), or 80 mM native Hb2m (black) at pH 7.2, 37
C, 200 rpm.
(B and C) De novo fibril assembly of 80 mM DN6 or DN6/H84A at pH 6.2 (red) or pH 8.2 (blue).
(D) Seeded fibril assembly of 80 mM DN6 at pH 6.2 (red) or pH 8.2 (blue) using 10% (w/w) DN6 fibrillar seeds. The error bars are the standard deviation of six
replicates. The presence of fibrillar material for all samples was confirmed by negative-stain electron microscopy (EM) (not shown).
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DN6 Converts Native Hb2m into an Amyloid-Competent
State
Given the inherent potential of DN6 to nucleate fibril formation
in vitro, we speculated that bimolecular collision between DN6
and Hb2m might enhance the amyloid potential of the latter
protein by its conversion to an amyloidogenic state, akin to
conformational conversion in prions. To test this hypothesis,
Hb2m and DN6 were incubated separately or as mixtures at
a final total concentration of 80 mM in ratios of 1:1, 1:9, or
1:99 (DN6:Hb2m) at pH 7.2, 37
C while shaking at 200 rpm
(Figure 5 and data not shown). Whereas Hb2m incubated alone
does not form fibrils in the time frame of the experiment
(100 days) (Figure 5A), consistent with previous results (Eichner
and Radford, 2009), 50% (1:1), 10% (1:9), or even 1% (1:99)
of DN6 is capable of catalyzing assembly of Hb2m into
amyloid-like fibrils with lag times of 30 ± 3, 40 ± 8, and
75 ± 8 days, respectively (Figures 5B and 5C and data not
shown). Crucially, these lag times are shorter than those
obtained when the same concentration of DN6 is incubated
alone (40 ± 5 days, 50 ± 7 days, and >100 days [Figures 5B
and 5C and data not shown]), indicating that productive interac-
tions betweenDN6 and Hb2mcatalyze assembly of the latter into
amyloid fibrils. As a control experiment, wild-type murine b2m
(Mb2m) was incubated alone or was mixed to a total protein
concentration of 80 mM with different concentrations of DN6
(50% [1:1], 10% [1:9], and 1% [1:99]) (Figures 5A–5C). Mb2m
is 70% identical in sequence to Hb2m but has been shown to
be unable to assemble into amyloid fibrils at acidic pH (Ivanova
et al., 2004). No fibrils were observed whenMb2mwas incubated
alone at pH 7.2, 37C for 100 days (Figure 5A). Remarkably, the
presence of stoichiometric concentrations of Mb2m abolishes
the ability of DN6 to form amyloid fibrils (Figure 5B), and catalytic
amounts (1%) of DN6 are not able to enhance amyloid formation
fromMb2m (Figure 5C). To confirm these findings, the amount of
soluble material remaining in each sample was quantified using
SDS-PAGE and fibril formation wasmonitored using EM (Figures
5A–5C). While all protein in 1:1 mixtures of DN6 and Mb2m
remained soluble (Figure 5B), 100%, 50%, and 10% conver-
sion of Hb2m into insoluble amyloid aggregates occurred when
the protein was incubated with 50% (1:1), 10% (1:9), or 1%
(1:99) DN6 (DN6:Hb2m), respectively, consistent with the
increased ThT fluorescence and the presence of fibrillar material
in EM images of these samples (Figures 5B and 5C). The results
indicate, therefore, that DN6 is able to convert Hb2m into
a conformer capable of forming amyloid fibrils even when added
in catalytic amounts. Bimolecular collision of DN6 with the highly
homologous Mb2m protein, by contrast, abolishes the aggrega-
tion potential of the truncated protein.
Atomistic Description of Conformational Conversion
by Bimolecular Collision of DN6 and Hb2m
To probe the molecular mechanism of conformational conver-
sion of Hb2m to an amyloidogenic state, backbone dynamics
of 15N-Hb2m in the absence or presence of
14N-DN6 (Figure 6A)
were assessed using 15N NMR R2 measurements at pH 6.2,
37C. These experiments revealed that adding 14N-DN6 to
15N-Hb2m increases the
15N relaxation rates of residues 13–22
in the AB-loop of Hb2m substantially (Figures 6A and 6C) in
a pH-dependent manner (Figure S4A). Addition of equivalent
concentrations of 14N-Hb2m or
14N-Mb2m has no effect on the
R2 relaxation rates of
15N-Hb2m (Figure 6B), indicating that the
interaction of DN6 with Hb2m is specifically able to alter
the dynamics of the latter protein. Note that the enhanced R2
relaxation rates of residues in the AB-loop of Hb2m in the pres-
ence ofDN6 are not accompanied by 1H-15N chemical shift alter-
ations (Figure S4B), implying that the concentration of the
encounter complex between Hb2m and DN6 is low (<5%) and
its formation occurs on an intermediate NMR timescale
(milliseconds).
The AB-loop (residues 13–22) (Figure 6C) has been shown to
adopt different conformations in different crystal structures of
Hb2m, dependent on the contacts made in the crystal lattice
(Ricagno et al., 2009). Additionally, it has been proposed that
Pro14, which introduces rigidity into the AB-loop (Figure 6C),
may play a role in triggering a conformational switch wherein
the A strand is displaced toward a more open protein conforma-
tion (Rosanoetal., 2004). As shownabove, suchaconformational
transition would favor relaxation of the X-Pro32 cis-peptide bond
to the trans-isomer by providing the conformational freedom
required for the structural changes linked to this isomerization
event to occur. To determine whether the increased dynamics
of the AB-loop of Hb2m induced by the presence ofDN6 is linked
to displacement of the A-strand, the hydrogen exchange (HX)
rates of individual residues of 15N-Hb2m, alone or mixed with
a molar equivalent of 14N-DN6, were determined at pH 6.2,
37C (Figure 6D). The results revealed a 2- to 3-fold increase in
the HX rates of residues in the N-terminal region of Hb2m in the
presence of 14N-DN6 (exemplified by Tyr10, Asn24, Tyr26, and
Ser28 in Figure 6D) compared to Hb2m alone. By contrast, little
effect (<1.5-fold) was observed for other residues in the protein
(exemplified by Leu64 and Lys91 in Figure 6D). The data thus
show that bimolecular collision of DN6 with Hb2m increases the
(E and F) 15N transverse relaxation measurements (R2 = 1/T2) of 500 mM (red) or 80 mM (blue) native Hb2morDN6 at pH 7.2, 25
C. Rainbow-colored ribbons above
indicate the secondary structure content of native Hb2m and DN6.
(G and H) 15N transverse relaxation measurements of 80 mMDN6 or DN6/H84A at pH 6.2 or pH 8.2 (red and blue, respectively) at 25C. Grey bars indicate a lower
limit of the R2 for residues too weak to determine the value more precisely (>25 s
1). Circles highlight residues for which R2 could not be determined due to reso-
nance overlap, line broadening, or the residue being a proline. Black crosses mark missing assignments. Green boxes highlight residues that show significant
differences in local backbone dynamics in the different samples. The error (E–H) was estimated using duplicates.
(I) Cartoon representation of five lowest-energy structures of DN6, highlighting Pro32 and His84 (sticks, spheres) and the regions that show enhanced local
dynamics (residues 26–35 [dark green] and 51–66 [light green-yellow]) in the different samples. Note that both Hb2m and DN6 show a uniform increase in R2 rates
at higher protein concentrations, which are distinct from the pH-dependent enhanced R2 rates measured for residues in spatial proximity to Pro32 in DN6. The
global increase in R2 rates observed for all residues in Hb2m and DN6 at increased protein concentration most likely indicates transient oligomerization not asso-
ciated with amyloid formation (see also Figure S3).
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conformational dynamics of the N-terminal region of the protein,
which permits the isomerization of the X-Pro32 bond and
switches on the pathway toward the amyloid state.
DISCUSSION
Role of the N Terminus in the Folding and Stabilization
of Hb2m
A key question in understanding amyloidosis is the nature of the
early conformational changes that tip the equilibrium from
correct folding toward the population of amyloidogenic species.
Furthermore, how bimolecular collisions between a native
protein and a misfolded or nonnative state enable conversion
of an initially innocuous protein into an amyloidogenic conforma-
tion remains poorly understood at a molecular level. Here, we
have used DN6 to investigate these phenomena. The solution
structure of DN6 shows that this amyloidogenic protein retains
a native-like structure, revealing that structural considerations
alone cannot explain the enhanced amyloidogenic potential of
this variant. Examination of the solution structures of native
Hb2m and DN6, nonetheless, reveals significant side-chain
rearrangements comprising more than half of the protein’s
core that occur when the X-Pro32 peptide bond isomerizes to
its trans-state, some of which involve residues shown hitherto
to undergo structural changes in conformers of b2m trapped in
protein crystals (Eakin et al., 2006; Calabrese et al., 2008).
Despite the structural similarities of DN6 in solution and Cu2+-
bound b2m observed crystallographically (Figures S2C–S2E),
only DN6 is able to form amyloid fibrils efficiently in vitro (Eichner
and Radford, 2009), suggesting that differences in structure and/
or dynamics of these species are critical in endowing the poten-
tial to form amyloid.
While DN6 retains a native topology and is only marginally
destabilized compared with Hb2m (DDG

UN = 3.8 kJ mol
1)
(Eichner and Radford, 2009), removal of the N-terminal six resi-
dues disrupts the kinetic stability of the protein, such that it is
no longer strongly protected from HX (Figure S3C) and intercon-
verts rapidly with other conformers on a microsecond-to-milli-
second timescale, as revealed by its enhanced R2 values
compared with Hb2m (Figures 4E and 4F). Furthermore, the
absence of well-resolved resonances for residues 1–7 in IT (Fig-
ure 1A) suggests that these residues are not natively attached to
the protein in this folding intermediate. The N-terminal residues
of b2m (Figure 7A, shown in blue) thus act as a postassembly
clamp, side chains in this region stabilizing residues in the
BC-loop and its main chain forming hydrogen bonds to the adja-
cent native b strand B. These interactions lock the X-Pro32
peptide bond in the cis-isomer, preventing its isomerization to
the relaxed trans-form and the consequent release of the side
chain of Phe30 from the hydrophobic core that, together, initiate
a cascade of events that opens up the pathway toward aggrega-
tion. Proline-mediated loop dynamics associated with protein
assembly have been observed in a number of protein systems
in vitro and in vivo, suggesting that proline-mediated triggering
of amyloidosis is not unique to b2m. For example, a misfolded
conformer of human immunoglobulin light chain (O’Nuallain
et al., 2007), an amyloid intermediate of stefin B (Jenko
Kokalj et al., 2007), and the cell-cycle protein p13suc1 (Rous-
seau et al., 2001) have all been shown to possess aggregation
mechanisms dependent on isomerization of X-Pro bonds.
DN6: An In Vivo Culprit of DRA
Despite the fact that b2m is among the most extensively studied
proteins involved in human amyloid disease (Platt and Radford,
Figure 5. Enhancement and Inhibition of Hb2m and DN6 Fibrillogenesis at pH 7.2 (37
C, 200 rpm)
(A) ThT fluorescence of 80 mM DN6 (red), Hb2m (black), or Mb2m (blue).
(B) ThT fluorescence of 40 mM DN6 incubated alone (red) or as mixtures of 40 mM Hb2m and 40 mM DN6 (black) or 40 mM Mb2m and 40 mM DN6 (blue).
(C) ThT fluorescence of 0.8 mM DN6 (red) or mixtures of 79.2 mMHb2m and 0.8 mM DN6 (black) or 79.2 mMMb2m and 0.8 mM DN6 (blue). The upper panels show
negative-stain EM images of the samples, using the same color coding. Scale bar = 100 nm. The insets (A–C) show SDS-PAGE analysis of the soluble fraction
obtained after centrifugation (14,000 3 g, 10 min) of the samples (see also Figure S5).
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2009), the initiating factors in DRA remain unclear. Many
scenarios have been suggested, including partial unfolding of
b2m on the collagen surface, mild acidification in arthritic joints,
stabilization of rare fibrils that may form from Hb2m by glycosa-
mingoglycans (Esposito et al., 2000; Yamamoto et al., 2004b; Ea-
kin andMiranker, 2005;Mimmi et al., 2006;Myers et al., 2006;Re-
lini et al., 2006), as well as mechanisms involving the addition of
metal ions, lipids, or other factors that enhance the initial unfold-
ing events required for assembly to occur (Yamamoto et al.,
2004a; Eakin andMiranker, 2005; Ohhashi et al., 2005; Sasahara
et al., 2008). Here, we have shown that DN6 is a highly amyloido-
genic species that is able to nucleate fibrillogenesis efficiently
in vitro at neutral pH. This observation rationalizes the lack of
circulating DN6 in the serum of patients with renal dysfunction
and, given the natural affinity of DN6 for collagen (which is
enhanced relative to Hb2m [Giorgetti et al., 2005]), explains why
assembly of fibrils occurs most readily in collagen-rich joints.
Additionally, we show that the mild acidification, such as may
occur in the synovial fluid of patients undergoing long-term
hemodialysis (Relini et al., 2006), has a dramatic effect in
enhancing fibril formation of DN6 and its ability to convert Hb2m
into an amyloid-competent state by protonation of His84 and/or
other residues in the protein. We propose that rather than being
an innocuous postassembly event (Monti et al., 2005), proteolytic
cleavage of the N-terminal region of b2m could be a key initiating
event in DRA. Such cleavage enables the formation of species
that are not only able to assemble de novo into amyloid fibrils,
which thereafter can enhance fibrillogenesis of Hb2m by cross-
seeding (Figure S5), but when present in only catalytic amounts
are also able to convert the wild-type protein into an amyloido-
genic state (Figure 5C).
Conformational Conversion in Atomistic Detail
A fascinating feature of amyloid fibrils is their ability to consume
soluble monomer for self-replication via elongation with their
own, or closely related, protein monomers. This suggests that
amyloid fibrils or misfolded protein aggregates in general may
have an inherent potential to convert innocuous protein
conformers into amyloidogenic species, a feature famously
associated with prions (Sindi and Serio, 2009). By exploring
Figure 6. Atomistic Details of Specific Interactions between Native Hb2m and DN6
(A and B) 15N transverse relaxationmeasurements (R2 = 1/T2) of 80 mM
15N-Hb2m in the absence (black) or presence (red) of 160 mM
14N-DN6 at pH 6.2, 37C, and
80 mM 15N-Hb2m in the presence of 160 mM
14N-Hb2m (black) or
14N-Mb2m (blue) under the same conditions. Circles highlight residues for which data could not be
obtained due to resonance overlap, line broadening, or the residue being proline. Black crosses mark missing assignments. Light yellow boxes emphasize resi-
dues 11–21 (AB-loop) that show increased backbone dynamics upon DN6 binding. The error was estimated using duplicates.
(C) Five lowest-energy structures of native Hb2m: Pro32 (light gray) and Pro14 (blue) are highlighted in sticks and spheres; the b strands A and B and the AB-loop
are rainbow colored from blue to cyan. Residues that establish essential hydrogen bonds between b strands A and B (Lys6-Ser28, Gln8-Tyr26, Tyr10-Asn24) are
highlighted in line representation alongside.
(D) H-D exchange rates of 80 mM 15N-Hb2malone (black) or in the presence of 160 mM
14N-DN6 (red) at pH 6.2, 37C. The black or red line is a single exponential fit
of the data obtained. The error was estimated from the noise level of the experiment. The bars alongside depict the H-D exchange rate constant (kex) of each
residue, colored in the same manner (see also Figure S4).
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the dynamics and aggregation behavior of DN6, this study
reveals that conformational excursions of DN6, which occur
more frequently upon mild acidification, not only rationalize the
inherent amyloidogenicity of this protein but also explain how
this species is able to convert Hb2m into an amyloidogenic state.
By contrast, transient bimolecular collision between DN6 and
Mb2m abolishes the ability of DN6 to convert into amyloid fibrils.
NMR analysis of bimolecular collisions between DN6 and
Hb2m (Figures 6A–6D) exposes atomistic details of one possible
route of conformational conversion during amyloid formation
(Figure 7B). First, protonation of His84 and/or other amino acid
side chains of DN6 under mild acidification enhances the aggre-
gation potential of this already amyloidogenic protein (Step 1,
Figure 7B). Next, specific bimolecular collision between DN6
and Hb2m alters the dynamic properties of the AB-loop in
Hb2m that contains Pro14, which leads to partial fraying or
displacement of the A-strand from the native b sandwich, with
concomitant loss of HX protection in this region (Step 2). By
this mechanism the X-Pro32 peptide bond becomes free to relax
to the trans-isomer, triggering the cascade of events involved in
the conversion of the constrained native protein to a dynamic
amyloidogenic state (Step 3). Further assembly of monomers
then leads to the formation of amyloid fibrils via one or more olig-
omeric species (Step 4). Correct docking of the A strand is thus
crucial in trapping the native protein into a unique conformation
and maintaining the concentration of amyloidogenic precursor
Figure 7. Turning On and Off b2m Amyloid Assembly
(A) Summary showing the structures of Hb2mand amodel of IT. Above, keys for these conformational states. Native Hb2m (leftmost), shown above as a circle with
cis-X-Pro32 (green G), trans-X-Pro14 (blue G), His84 (red circle), and the N-terminal region (residues 1–6, in blue). Upon dissociation of the N-terminal region, the
X-Pro32 bond is free to relax into the trans-conformation, causing further conformational changes that lead to the formation of the nonnative IT conformer (shown
as a circle above a model of its structure). Protonation of His84 (shown in red and as a red circle above), which lies adjacent to Pro32 under mildly acidic condi-
tions, further enhances the amyloid potential of IT. Oligomerization of these aggregation-prone species then leads to the formation of b2m amyloid fibrils.
Assuming that the fibrils formed at neutral pH are structurally similar to those formed at acidic pH, as suggested by FTIR (Jahn et al., 2008) and solid-state
NMR (Debelouchina et al., 2010), large conformational changes are required in order to transform the antiparallel b sheet arrangement of DN6 into the parallel
in-register arrangement of b strands characteristic of b2m amyloid fibrils, as reported recently (Ladner et al., 2010).
(B) Proposedmechanism of conformational conversion of Hb2m into an amyloid-competent state by bimolecular collision withDN6.DN6 (shown schematically as
a circle, using similar color schemes as in A) lacks the N-terminal six residues that clampHb2m into its native structure. Protonation of His84 (shown as a red circle
[unprotonated] or square [protonated]) occurs at mildly acidic pH. Possibly accompanied by alterations in the conformation/protonation status of other residues,
the amyloidogenicity ofDN6 is enhanced (Step 1). Bimolecular collision of one ormore rarely populated conformers ofDN6with native Hb2m leads to dissociation
of the N-terminal region of the latter protein, allowing cis-to-trans isomerization of X-Pro32 to occur (Step 2). Subsequent protonation of His84 in the wild-type
protein is then favored, completing conformational conversion of IT (Step 3). Further protein-protein interactions between these species then allow nucleation and
elongation of amyloid fibrils (Step 4).
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states below that required for amyloid formation. Exploiting the
power of NMR,we reveal here in atomistic detail how a nonnative
protein conformer is able to convert an originally innocuous
native protein species into an amyloidogenic state, opening the
door to protein self-assembly and the onset of amyloidosis.
EXPERIMENTAL PROCEDURES
Protein Preparation
Proteins were prepared as previously described (Platt et al., 2005).
Assembly of Amyloid Fibrils
Samples were prepared in 96-well plates (Corning Incorporated, Costar)
containing 0.8–500 mM protein, 81–89.5 mM NaCl, 10 mM ThT, and 0.02%
(w/v) sodium azide in 10 mM sodium phosphate buffer (pH 6.2–8.2). Seeded
reactions contained additionally 10% (w/w) DN6 seeds (see Supplemental
Experimental Procedures). De novo fibril growth was performed by incubating
the 96-well plate at 37C, 200 rpm, while seeded reactions were carried out
quiescently at 37C. ThT fluorescence (excitation 440 nm, emission 480 nm)
was measured using a plate reader (FLUOstar OPTIMA) at 37C. The soluble
fraction obtained after centrifugation (14,000 3 g, 10 min) was analyzed by
SDS-PAGE.
NMR Spectroscopy and Structure Determination
Samples of 15N- or 13C-15N-labeled protein (0.3–1.0 mM) in 25 mM sodium
phosphate buffer pH 7.5, 0.02% (w/v) sodium azide, 90% (v/v) H2O/10%
(v/v) D2O were used for NMR experiments.
Spectra were recorded at 25C on a Varian Inova 500 MHz or 600 MHz
instrument with a room temperature probe or a Varian Inova 750 MHz spec-
trometer equipped with a cryogenic probe. Sequential assignment, structural
restraint, structure calculation, and other NMR procedures are detailed in the
Supplemental Experimental Procedures online.
15N NMR Relaxation, Saturation Transfer, and HX Experiments
Backbone 15N transverse relaxation (R2 = 1/T2),
15N longitudinal relaxation
(R1 = 1/T1), {
1H}15N nOe relaxation measurements, and measurements of HX
were carried out as described (Farrow et al., 1994; Gorski et al., 2004). Further
details are given in the Supplemental Experimental Procedures online.
ACCESSION NUMBERS
Coordinates and structural restraints of Hb2mandDN6 have been deposited in
the PDB and chemical shifts, peak lists, and rdc measurements in BMRB with
accession numbers 2XKS and 17165 or 2XKU and 17166, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, five figures, and two tables and can be found
with this article online at doi:10.1016/j.molcel.2010.11.028.
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